Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,561,181
-$769,326 QoQ
Shares Held
21,897
-15.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,543
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Qtron Investments LLC holds $33,905,175 across 13 Drug Manufacturers - General names. JNJ ranks #2 (16.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,521 | $9,020,913 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
21,897 | $5,561,181 | |
| 3 | ABBV |
AbbVie Inc.
|
17,841 | $4,489,509 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,088 | $2,581,308 | |
| 5 | AMGN |
Amgen Inc
|
6,469 | $2,342,554 | |
| 6 | AZN |
Astrazeneca PLC
|
11,190 | $2,121,847 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,328 | $1,689,879 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
12,413 | $1,568,258 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,561,181 | 21,897 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,330,507 | 25,898 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,357,935 | 25,890 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,840,544 | 31,499 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,039,473 | 26,445 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,385,638 | 26,445 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,769,086 | 26,062 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,741,389 | 29,257 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,630,760 | 24,841 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,929,597 | 24,841 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,385,740 | 21,601 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,364,355 | 21,601 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,162,828 | 25,150 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,652,420 | 23,564 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,091,214 | 23,160 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,628,879 | 22,214 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,631,768 | 26,093 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,101,633 | 23,143 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $4,145,881 | 24,235 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $3,840,470 | 23,780 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,650,638 | 22,160 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,485,370 | 21,207 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,464,885 | 15,662 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,937,822 | 13,016 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,855,894 | 13,197 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,092,179 | 15,955 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||